Martin and Harris Laboratories Limited
+100 %As of April 24, 2025, Martin and Harris Laboratories Limited share price is INR 975.00 per share and the face value is INR 0 per share. The lot size of Martin and Harris Laboratories Limited is 0 shares. The 52 week high for Martin and Harris Laboratories Limited is INR 975.00, while the 52 week low is INR 975.00
About Martin and Harris Laboratories Limited
A Comprehensive Overview of Price & Journey
Understanding Martin and Harris Laboratories Limited Inception and Growth
SHOW MORE...About Martin and Harris Laboratories Limited
IPO Details, Price movement
Performance Highlights for FY 2023-24
-
Revenue from operation decreased by 29% from INR 205 crore in FY23 to INR 146 crore in FY24.
-
Total Revenue decreased by 21 % from INR 229.2 crore in FY23 to INR 180.4 crore in FY24.
-
Profit Before Tax decreased by 40% from INR 92.1 crore in FY23 to INR 55.2 crore in FY24.
-
The Company’s Profit After Tax declined by 41% from INR 68.1 crore in FY23 to INR 40.4 crore in FY24.
-
Net Cash used in Operating activities was INR 344 crore in FY23 and INR 20 crore in FY24.
-
Cash flow from investing activities was INR 325 crore in FY23 and Net Cash used in investing activities was INR 21 crore in FY24.
-
Net cash used in Financing activities was INR 2 crore in FY23 and INR 1 crore in FY24.
Fundamentals
Market Cap (in cr.)
₹ 0
P/E Ratio
0
P/B Ratio
0
Debt to Equity
0.00
ROE (%)
0
Book Value
0
Face Value
0
Total Shares
0
Category
Unlisted Shares
Unlisted CMP
₹ 0 /
Share
Lot Size
0 Shares
52 Week High
₹975.00
52 Week Low
₹975.00
Depository
0
PAN Number
-
ISIN Number
-
CIN
-
Sector
Health Care
Financials
| P&L Statement | - | - | - | - |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Other Income | - | - | - | - |
| COGS | - | - | - | - |
| Gross Profit | - | - | - | - |
| Total Expense | - | - | - | - |
| EBIDTA | - | - | - | - |
| D&A | - | - | - | - |
| EBIT | - | - | - | - |
| Interest Expense | - | - | - | - |
| PBT | - | - | - | - |
| TAX | - | - | - | - |
| PAT | - | - | - | - |
| Diluted EPS | - | - | - | - |
| Basic EPS | - | - | - | - |
| Total income | 0.00 | 0.00 | 0.00 | 0.00 |
ASSETS
| CURRENT ASSETS | - | - | - | - |
|---|---|---|---|---|
| Cash and Cash Equivalents | - | - | - | - |
| Trade Payables | - | - | - | - |
| Inventory | - | - | - | - |
| Other Current Assets | - | - | - | - |
| Total Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| NON CURRENT ASSETS | - | - | - | - |
|---|---|---|---|---|
| Plant Property and Equipment | - | - | - | - |
| Long Term Investment | - | - | - | - |
| Other Non Current Assets | - | - | - | - |
| TOTOAL NON CURRENT ASSSETS | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 0.00 | 0.00 | 0.00 | 0.00 |
|---|
| CURRENT LIABILITES | - | - | - | - |
|---|---|---|---|---|
| TRADW Payable | - | - | - | - |
| Other Current Liab | - | - | - | - |
| Total Current Liab | 0.00 | 0.00 | 0.00 | 0.00 |
| NON CURRENTLIABILITIES | - | - | - | - |
|---|---|---|---|---|
| Long Term Debt | - | - | - | - |
| Deffered Tax Liab | - | - | - | - |
| Other Non Current Liab | - | - | - | - |
LIABILITIES
| EQUITY | - | - | - | - |
|---|---|---|---|---|
| Share Capital | - | - | - | - |
| Reserves And Surplus | - | - | - | - |
| Other Equity | - | - | - | - |
| Retained Earnings | - | - | - | - |
| share Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
|---|
| CASH FLOW STAT | - | - | - | - |
|---|---|---|---|---|
| Cash Flow from operating | - | - | - | - |
| Cash Flow from financing | - | - | - | - |
| Cash Flow from investing | - | - | - | - |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue Growth
PAT Growth %
EPS Growth %
TOTAL ASSETS Growth %
QUICK RATIO Growth %
LONG TERM DEBT TO EQUITY RATIO Growth %
Events
| Name | Date | Details |
|---|---|---|
| No events available. | ||
Promoters or Management
| Name | Designation | Linkedin Profile | |
|---|---|---|---|
| No promoters available. | |||
Frequently Asked Questions
Martin and Harris1. How to Martin and Harris Laboratories Limited/Pre-IPO shares? Laboratories Limited
- Please find below the procedure for buying Martin and Harris Laboratories Limited/Pre-IPO shares at Bharat Invest.
- You confirm booking of Martin and Harris Laboratories Limited/Pre-IPO shares with us at a specified price.
- You have to provide your client master report along with PAN Card and Cancelled Cheque in case you are not transferring funds from the bank account as mentioned in the CMR Copy. These are KYC documents required as per SEBI regulations.
- We will provide our bank details.
- You need to transfer funds in the current account of bharat invest.
- No cash deposit is accepted
- Payment has to be done from the same account in which shares are to be credited.
- We ensure delivery of Martin and Harris Laboratories Limited within 24 hours.
- Incase of non-availability of shares, we refund the amount to the same bank account within 24 hours.
- For detailed discussion, you can contact us via any medium.
2. How to sell Martin and Harris Laboratories Limited/Pre-IPO shares?
3. What is the lock-in period of Martin and Harris Laboratories Limited/Pre-IPO shares after the shares gets listed?
4. What is the average ticket size for investing in unlisted shares?
5. How to check credit of Martin and Harris Laboratories Limited/Pre-IPO shares?
6. How is valuation of Martin and Harris Laboratories Limited/Pre-IPO shares is decided?
7. How do we get delivery of the Martin and Harris Laboratories Limited/pre-ipo shares shares?
8. What is the safety regarding the payment?
9. Difference Between Unlisted Company & Listed Company?
10. Short-term Capital Gain taxes to be paid on Unlisted Shares/Pre-IPO shares?
11. Long-term Capital Gain taxes to be paid on Unlisted Shares/Pre-IPO shares?
12. Applicability of Taxes on Unlisted Shares/Pre-IPO shares once it is listed?
13. IS PRE IPO market same as grey market?
14. Who sells private shares?
15. Investing in Martin and Harris Laboratories Limited legal in India?
16. Is Bharat invest a trustable source to invest in unlisted shares?